Verve Therapeutics, Inc.: SCHEDULE 13G/A filed Jul 28, 2025

Form type

SCHEDULE 13G/A

Filing date

Jul 28, 2025

Accession number

0001415889-25-020385

Filer

Verve Therapeutics, Inc. (CIK 1840574)